PT - JOURNAL ARTICLE AU - Lim, Chanho AU - Chung, Yunsung AU - Hamm, Jihun AU - Ding, Zhengming AU - Mekhael, Mario AU - Noujaim, Charbel AU - Assaf, Ala AU - Younes, Hadi AU - Chouman, Nour AU - Makan, Noor AU - Donnellan, Eoin AU - Marrouche, Nassir TI - Generalizability and Clinical Implications of Electrocardiogram Denoising with Cardio-NAFNet AID - 10.1101/2022.10.26.22281565 DP - 2022 Jan 01 TA - medRxiv PG - 2022.10.26.22281565 4099 - http://medrxiv.org/content/early/2022/10/27/2022.10.26.22281565.short 4100 - http://medrxiv.org/content/early/2022/10/27/2022.10.26.22281565.full AB - The rise of mobile electrocardiogram (ECG) devices came with the rise of frequent large magnitudes of noise in their recordings. Several artificial intelligence (AI) models have had great success in denoising, but the model’s generalizability and the enhancement in clinical interpretability are still questionable. We propose Cardio-NAFNet, a novel AI-based approach to ECG denoising by employing a modified version of Non-Linear Activation Free Network (NAFNET). We conducted three experiments for quantitative and qualitative evaluation of denoising, clinical implications and generalizability. In the first experiment, Cardio-NAFNet achieved 53.74dB average signal to noise ratio across varying magnitude of noise in beat-to-beat denoising, which is a significant improvement over the current state of the art model in ECG denoising. In the second experiment, we tested the enhancement in clinical interpretation of the ECG signals by utilizing a pretrained ECG classifier using 8 second long noise-free ECG signals. When the classifier was tested using noisy ECG signals and their denoised counterparts, Cardio-NAFNet’s denoised signals provided 26% boost in classification results. Lastly, we provide an external validation dataset composed of single-lead mobile ECG signals along with signal quality evaluation from physician experts. Our paper suggests a settling method to capture and reconstruct critical features of ECG signals not only in terms of quantitative evaluation, but also through generalizable qualitative evaluation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding received for the studyAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used to train the model (Physionet MIT-BIH Arrhythmia Database and Noise-Stress Database) are public on Physionet. https://physionet.org/